Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
CHIRON logo — Innovative products and solutions for the biomedical industr...

CHIRON

Innovative products and solutions for the biomedical industry, regenerative medicine and drug delivery.

Founded 2020 The Netherlands The Netherlands 2-10 employees Biotechnology, VR/AR +1

General Information

Company Name CHIRON
Founded Year 2020
Location The Netherlands The Netherlands +1
Employees 2-10
Industries Biotechnology, VR/AR, 3D Printing
Social

Get notified when CHIRON moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About CHIRON

CHIRON is a consortium of companies and research institutes based in The Netherlands, focused on providing innovative solutions for the biomedical sector. The company aims to develop a bio-inkjet platform for research and clinical use, enabling the patterning of a portfolio of biomaterials, matrices, and cells with high spatiotemporal resolution. The platform is designed to create complex biomimetic tissue micro- and macro-environments with unprecedented speed and resolution, with osteochondral tissue as demonstrator cases. The consortium includes organizations such as Concr3de BV, IPC (Innovative Polymer Compounds), the department of Biofabrication of UMCUtrecht, and the department of Biofabrication of Trinity College of Dublin. CHIRON operates in the Biotechnology, VR/AR, and 3D Printing industries and was founded in 2020. As of now, there is no publicly disclosed information about the last investment or the investors involved. The company's mission to provide innovative products and solutions for the biomedical industry, regenerative medicine, and drug delivery reflects a promising endeavor in the field of biotechnology.

Taxonomy: Biomedical Industry, Regenerative Medicine, Drug Delivery, Biofabrication, 3D Bioprinting, Biomaterials, Consortium, Research and Development, Innovation, Tissue Engineering, Bioprinting Technology, Collaborative Research, Cell Patterning

No funding data available for CHIRON yet.

Get notified when CHIRON raises funding

CHIRON Alternatives & Competitors

CHIRON vs
T&RBiofab
T&RBiofab Korea South

Where bioprinting, stem cells and biomaterials meet to change people's lives

Post Ipo Equity
30 employees
Biotechnology, Manufacturing
CHIRON vs
Vital3D Technologies
Vital3D Technologies Lithuania

We develop advanced 3D tools for the future of personalized medicine.

13 employees
Biotechnology, Pharmaceutical
CHIRON vs
AdBioInk Biosystem Technology
AdBioInk Biosystem Technology Turkey

All for health

2 employees
Biotechnology, Digital Health

FAQ About CHIRON

Innovative products and solutions for the biomedical industry, regenerative medicine and drug delivery.
CHIRON was founded in 2020.
CHIRON is headquartered in The Netherlands.
CHIRON operates in the following industries: Biotechnology, VR/AR, 3D Printing.
CHIRON has approximately 2-10 employees.
Top alternatives and competitors to CHIRON include T&RBiofab, Vital3D Technologies, AdBioInk Biosystem Technology, Foldink, TissueVision, Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CHIRON and T&RBiofab are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors CHIRON and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy